Table_4_Effectiveness of a Yoga-Based Lifestyle Protocol (YLP) in Preventing Diabetes in a High-Risk Indian Cohort: A Multicenter Cluster-Randomized Controlled Trial (NMB-Trial).docx
Though several lines of evidence support the utility of yoga-based interventions in diabetes prevention, most of these studies have been limited by methodological issues, primarily sample size inadequacy. Hence, we tested the effectiveness of yoga-based lifestyle intervention against diabetes risk reduction in multicentre, large community settings of India, through a single-blind cluster-randomized controlled trial, Niyantrita Madhumeha Bharat Abhiyan (NMB).
Research Design and MethodsNMB-trial is a multicentre cluster-randomized trial conducted in 80 clusters [composed of rural units (villages) and urban units (Census Enumeration Blocks)] randomly assigned in a 1:1 ratio to intervention and control groups. Participants were individuals (age, 20–70 years) with prediabetes (blood HbA1c values in the range of 5.7–6.4%) and IDRS ≥ 60. The intervention included the practice of yoga-based lifestyle modification protocol (YLP) for 9 consecutive days, followed by daily home and weekly supervised practices for 3 months. The control cluster received standard of care advice for diabetes prevention. Statistical analyses were performed on an intention-to-treat basis, using available and imputed datasets. The primary outcome was the conversion from prediabetes to diabetes after the YLP intervention of 3 months (diagnosed based upon HbA1c cutoff >6.5%). Secondary outcome included regression to normoglycemia with HbA1c <5.7%.
ResultsA total of 3380 (75.96%) participants were followed up at 3 months. At 3 months post-intervention, overall, diabetes developed in 726 (21.44%) participants. YLP was found to be significantly effective in halting progression to diabetes as compared to standard of care; adjusted RRR was 63.81(95% CI = 56.55–69.85). The YLP also accelerated regression to normoglycemia [adjusted Odds Ratio (adjOR) = 1.20 (95% CI, 1.02–1.43)]. Importantly, younger participants (≤40 years) were found to regress to normoglycemia more effectively than the older participants Pinteraction<0.001.
ConclusionBased on the significant risk reduction derived from the large sample size, and the carefully designed randomized yoga-based intervention on high-risk populations, the study is a preliminary but strong proof-of-concept for yoga as a potential lifestyle-based treatment to curb the epidemic of diabetes. The observed findings also indicate a potential of YLP for diabetes prevention in low/moderate risk profile individuals that needs large-scale validation.
Trial RegistrationClinical Trial Registration Number: CTRI/2018/03/012804.
History
References
- https://doi.org//10.1016/j.diabres.2019.107843
- https://doi.org//10.1016/S0140-6736(12)60283-9
- https://doi.org//10.1056/NEJMoa012512
- https://doi.org//10.2337/diacare.20.4.537
- https://doi.org//10.2337/diacare.26.12.3230
- https://doi.org//10.1016/j.diabres.2004.06.010
- https://doi.org//10.1007/s00125-005-0097-z
- https://doi.org//10.1016/j.pcd.2011.04.005
- https://doi.org//10.2337/dc16-1241
- https://doi.org//10.1016/j.pcd.2018.07.003
- https://doi.org//10.2337/dc13-1954
- https://doi.org//10.1016/j.diabres.2010.06.030
- https://doi.org//10.1155/2012/165410
- https://doi.org//10.3389/fnhum.2014.00770
- https://doi.org//10.3389/fnhum.2018.00067
- https://doi.org//10.1371/journal.pone.0221067
- https://doi.org//10.1155/2016/6979370
- https://doi.org//10.1002/14651858.CD011658
- https://doi.org//10.1016/j.ctim.2016.02.001
- https://doi.org//10.4103/2230-8210.141318
- https://doi.org//10.1186/1472-6882-14-212
- https://doi.org//10.2337/dc14-2814
- https://doi.org//10.4103/ijoy.IJOY_40_18
- https://doi.org//10.4103/ijoy.IJOY_38_19
- https://doi.org//10.4103/2230-8210.107825
- https://doi.org//10.2337/dc13-S011
- https://doi.org//10.1016/j.jdiacomp.2017.01.005
- https://doi.org//10.2337/dc17-S007
- https://doi.org//10.1111/j.1365-3156.2006.01736.x
- https://doi.org//10.4103/2229-3485.83221
- https://doi.org//10.1136/bmj.326.7382.219
- https://doi.org//10.2337/diacare.26.5.1380
- https://doi.org//10.1007/s00109-006-0134-5
- https://doi.org//10.2337/dc07-2162
- https://doi.org//10.2337/dc08-1138
- https://doi.org//10.1186/s12889-019-6445-6
- https://doi.org//10.1371/journal.pmed.1002575
- https://doi.org//10.1186/s12889-015-1379-0
- https://doi.org//10.1016/j.cdtm.2016.11.013
- https://doi.org//10.2337/db13-1592
- https://doi.org//10.2337/dc19-0244
- https://doi.org//10.1016/S0140-6736(09)61457-4
- https://doi.org//10.1111/j.1464-5491.2007.02068.x
- https://doi.org//10.1016/S0140-6736(18)33015-0
- https://doi.org//10.1136/jcp.2007.054304
- https://doi.org//10.1371/journal.pone.0092458
- https://doi.org//10.1186/s12874-017-0368-7